Hogue Dale Curtis Jr. 4
4 · Alaunos Therapeutics, Inc. · Filed Jan 3, 2024
Insider Transaction Report
Form 4
Hogue Dale Curtis Jr.
DirectorSee Remarks
Transactions
- Award
Employee Stock Option (right to buy)
2023-12-29+150,000→ 150,000 totalExercise: $0.07Exp: 2033-12-28→ Common Stock (150,000 underlying) - Award
Employee Stock Option (right to buy)
2023-12-29+41,667→ 41,667 totalExercise: $0.07Exp: 2033-12-28→ Common Stock (41,667 underlying)
Footnotes (2)
- [F1]One-thirty sixth of the shares underlying the option vest in equal monthly installments measured from December 29, 2023, with the first vesting occurring on January 29, 2024, subject to the Reporting Person's continued service through each such date.
- [F2]In five equal monthly installments measured from December 29, 2023, with the first vesting occurring on January 29, 2024, subject to the Reporting Person's continued service through each such date.